S

Sail Biomedicines

In vivo programmable RNA CAR-T therapies

Scientist: Platform RNA Sciences

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$98k - $125kIn-person

About the Job

Requirements

  • Hold a Ph.D. in Molecular Biology, Biochemistry, or a related field, or an M.S. with 6+ years of focused, full-time research experience in RNA technologies.
  • Have a strong background in RNA biology and demonstrated skills in relevant molecular and biochemical techniques, including in vitro transcription, RNA purification, oligo-dT purification, column chromatography, capillary gel electrophoresis, RT-qPCR, RNA-seq, and Nanopore sequencing.
  • Have experience using data analysis and information management tools such as Excel, GraphPad Prism, R, JMP, SnapGene, Benchling, Smartsheet, and Jira.
  • Be able to independently design and carry out experiments.
  • Be able to manage multiple tasks and prioritize them.
  • Maintain excellent record keeping.

Responsibilities

  • Conceive and conduct pooled and array screens to improve eRNA designs, enabling higher product purity and function.
  • Design hypothesis-driven experiments based on state-of-the-art RNA biology to refine eRNA designs.
  • Evaluate and develop alternative circularization strategies.
  • Determine circularization efficiency and impurity levels by running analytical assays.
  • Design properly controlled experiments, generate high-quality data, and run rigorous statistical analysis.
  • Maintain detailed documentation in electronic lab notebooks.
  • Author standard operating procedures, study summaries, and technical reports.
  • Present findings clearly in oral or written formats to internal and external stakeholders to enable alignment and decision-making.

Desired Qualifications

  • Experience in next-generation sequencing library preparation.
  • Working knowledge of engineering ribozymes, aptamers, or other complex RNA structures.

About the Company

Sail Biomedicines

In vivo programmable RNA CAR-T therapies

Sail Biomedicines creates programmable RNA medicines that enable in vivo CAR-T therapies for autoimmune diseases, turning the patient’s body into the site of T-cell engineering. Its platform combines Endless RNA circular RNA, a library of targeted nanoparticles for cell-specific delivery, and AI-powered design tools to program T cells inside the body. It differentiates from competitors by delivering and programming CAR-T cells in vivo rather than via ex vivo cell manufacturing, leveraging circular RNA and targeted nanoparticles, with support from its Flagship Pioneering lineage and a Johnson & Johnson collaboration. The goal is to provide scalable, durable immune resets and remission for immune-mediated diseases with broader, more accessible treatments.

Company size
51-200
Company stage
Acquired
Total funding
Not listed
Headquarters
United States
Founded
2023

Recently Posted Jobs

Explore more opportunities at Sail Biomedicines

See more jobs